Skip to main content

Peer Review reports

From: Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China

Original Submission
11 Sep 2023 Submitted Original manuscript
26 Feb 2024 Reviewed Reviewer Report
14 Mar 2024 Reviewed Reviewer Report
28 Mar 2024 Author responded Author comments - Quan Zhao
11 Apr 2024 Reviewed Reviewer Report
18 Apr 2024 Reviewed Reviewer Report
27 Apr 2024 Author responded Author comments - Quan Zhao
Resubmission - Version 2
28 Mar 2024 Submitted Manuscript version 2
3 May 2024 Reviewed Reviewer Report - Ee Vien Low
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 May 2024 Editorially accepted
9 May 2024 Article published 10.1186/s12889-024-18778-2

You can find further information about peer review here.

Back to article page